Oxyntomodulin-based therapy for lowering cholesterol, and triglycerides levels: Oxyntomodulin (OXM), a 37 amino acid intestinal peptide that  inhibits food intake and body weight, decreases the levels of HMGCR,  triglycerides, free cholesterol, and total cholesterol and prevents the progression of Non-alcoholic fatty liver disease (NAFLD), via up-regulation of its target gene, 29/April/2019, 2.58 pm